RYBELSUS 7 MG COM OR CT BL AL AL X 90
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1176600370080 -
GGREM
526620120008907 -
Código de barras
7897705202739
O que a fonte publica
- Detentor do registro
- NOVO NORDISK FARMACÊUTICA DO BRASIL LTDA
- Princípios ativos
- SEMAGLUTIDA
- Embalagem
- 7 MG COM OR CT BL AL AL X 90
- Tipo de produto
- Biológico
- Classe terapêutica
- A10S - ANTIDIABÉTICOS AGONISTAS DE GLP-1
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "RYBELSUS 7 MG COM OR CT BL AL AL X 90",
"holder": "NOVO NORDISK FARMACÊUTICA DO BRASIL LTDA",
"stripe": null,
"barcodes": [
"7897705202739"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "526620120008907",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "82.277.955/0001-55",
"priceRegime": "Regulado",
"productName": "RYBELSUS",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "7 MG COM OR CT BL AL AL X 90",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "2582.55",
"icms-12": "2934.72",
"icms-17": "3111.51",
"icms-18": "3149.45",
"icms-19": "3188.33",
"icms-20": "3228.19",
"icms-21": "3269.05",
"icms-22": "3310.96",
"icms-23": "3353.96",
"icms-17.5": "3130.36",
"icms-19.5": "3208.14",
"icms-20.5": "3248.49",
"icms-22.5": "3332.32",
"icms-12-alc": "2620.28",
"icms-17-alc": "2778.13",
"icms-18-alc": "2812.01",
"icms-19-alc": "2846.72",
"icms-20-alc": "2882.31",
"icms-21-alc": "2918.80",
"icms-22-alc": "2956.21",
"icms-23-alc": "2994.61",
"withoutTaxes": "2305.85",
"icms-17.5-alc": "2794.97",
"icms-19.5-alc": "2864.41",
"icms-20.5-alc": "2900.44",
"icms-22.5-alc": "2975.29"
},
"pisCofinsList": "Negativa",
"substanceText": "SEMAGLUTIDA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "3464.40",
"icms-12": "3936.82",
"icms-17": "4173.98",
"icms-18": "4224.88",
"icms-19": "4277.03",
"icms-20": "4330.50",
"icms-21": "4385.31",
"icms-22": "4441.53",
"icms-23": "4499.22",
"icms-17.5": "4199.27",
"icms-19.5": "4303.61",
"icms-20.5": "4357.73",
"icms-22.5": "4470.19",
"icms-12-alc": "3622.38",
"icms-17-alc": "3840.60",
"icms-18-alc": "3887.44",
"icms-19-alc": "3935.42",
"icms-20-alc": "3984.62",
"icms-21-alc": "4035.07",
"icms-22-alc": "4086.79",
"icms-23-alc": "4139.87",
"withoutTaxes": "3187.70",
"icms-17.5-alc": "3863.88",
"icms-19.5-alc": "3959.88",
"icms-20.5-alc": "4009.69",
"icms-22.5-alc": "4113.16"
},
"invalidBarcodes": [],
"activeSubstances": [
"SEMAGLUTIDA"
],
"therapeuticClass": "A10S - ANTIDIABÉTICOS AGONISTAS DE GLP-1",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1176600370080",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "A10S",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:526620120008907"